| 24 HR donepezil hydrochloride 10 MG / memantine hydrochloride 28 MG Extended Release Oral Capsule [Namzaric] donepezil hydrochloride | 1,240 | 24.5%
| T3 | 6.9% | 21,609 |
| tolvaptan 15 MG Oral Tablet [Jynarque] tolvaptan | 1,237 | 24.4%
| T4 | 98.9% | 1,228 |
| tolvaptan 30 MG Oral Tablet [Jynarque] tolvaptan | 1,237 | 24.4%
| T4 | 98.9% | 1,228 |
| levonorgestrel 0.000833 MG/HR Intrauterine System [Mirena] levonorgestrel | 1,214 | 24%
| T3 | 3.3% | 650 |
| alanine 10.4 MG/ML / arginine 5.75 MG/ML / calcium chloride 0.004 MEQ/ML / dibasic potassium phosphate 2.61 MG/ML / glucose 150 MG/ML / glycine 5.15 MG/ML / histidine 2.4 MG/ML / isoleucine 3 MG/ML / leucine 3.65 MG/ML / lysine 2.9 MG/ML / magnesium chloride 0.01 MEQ/ML / methionine 2 MG/ML / phenylalanine 2.8 MG/ML / proline 3.4 MG/ML / serine 2.5 MG/ML / sodium acetate trihydrate 3.4 MG/ML / sodium chloride 0.01 MEQ/ML / threonine 2.1 MG/ML / tryptophan 0.9 MG/ML / tyrosine 0.2 MG/ML / valine 2.9 MG/ML Injectable Solution [Clinimix E 5/15] alanine | 1,214 | 24%
| T3 | 90.5% | - |
| alanine 5.7 MG/ML / arginine 3.16 MG/ML / calcium chloride 0.004 MEQ/ML / dibasic potassium phosphate 2.61 MG/ML / glucose 50 MG/ML / glycine 2.83 MG/ML / histidine 1.32 MG/ML / isoleucine 1.65 MG/ML / leucine 2.01 MG/ML / lysine 1.59 MG/ML / magnesium chloride 0.01 MEQ/ML / methionine 1.1 MG/ML / phenylalanine 1.54 MG/ML / proline 1.87 MG/ML / serine 1.38 MG/ML / sodium acetate trihydrate 2.17 MG/ML / sodium chloride 0.02 MEQ/ML / threonine 1.16 MG/ML / tryptophan 0.5 MG/ML / tyrosine 0.11 MG/ML / valine 1.6 MG/ML Injectable Solution [Clinimix E 2.75/5] alanine | 1,214 | 24%
| T3 | 90.5% | - |
| alanine 8.8 MG/ML / arginine 4.89 MG/ML / calcium chloride 0.004 MEQ/ML / dibasic potassium phosphate 2.61 MG/ML / glucose 50 MG/ML / glycine 4.38 MG/ML / histidine 2.04 MG/ML / isoleucine 2.55 MG/ML / leucine 3.11 MG/ML / lysine 2.47 MG/ML / magnesium chloride 0.01 MEQ/ML / methionine 1.7 MG/ML / phenylalanine 2.38 MG/ML / proline 2.89 MG/ML / serine 2.13 MG/ML / sodium acetate trihydrate 2.97 MG/ML / sodium chloride 0.013 MEQ/ML / threonine 1.79 MG/ML / tryptophan 0.77 MG/ML / tyrosine 0.17 MG/ML / valine 2.47 MG/ML Injectable Solution [Clinimix E 4.25/5] alanine | 1,214 | 24%
| T3 | 90.5% | - |
| alanine 10.4 MG/ML / arginine 5.75 MG/ML / calcium chloride 0.004 MEQ/ML / dibasic potassium phosphate 2.61 MG/ML / glucose 200 MG/ML / glycine 5.15 MG/ML / histidine 2.4 MG/ML / isoleucine 3 MG/ML / leucine 3.65 MG/ML / lysine 2.9 MG/ML / magnesium chloride 0.01 MEQ/ML / methionine 2 MG/ML / phenylalanine 2.8 MG/ML / proline 3.4 MG/ML / serine 2.5 MG/ML / sodium acetate trihydrate 3.4 MG/ML / sodium chloride 0.01 MEQ/ML / threonine 2.1 MG/ML / tryptophan 0.9 MG/ML / tyrosine 0.2 MG/ML / valine 2.9 MG/ML Injectable Solution [Clinimix E 5/20] alanine | 1,214 | 24%
| T3 | 90.5% | - |
| acetaminophen 300 MG / hydrocodone bitartrate 7.5 MG Oral Tablet acetaminophen | 1,209 | 23.9%
| T3 | 0% | 156 |
| acetaminophen 300 MG / hydrocodone bitartrate 10 MG Oral Tablet acetaminophen | 1,209 | 23.9%
| T3 | 0% | 156 |
| tretinoin 0.001 MG/MG Topical Gel tretinoin | 1,207 | 23.8%
| T4 | 81.8% | 91,688 |
| omaveloxolone 50 MG Oral Capsule [Skyclarys] omaveloxolone | 1,207 | 23.8%
| T5 | 98.1% | 321 |
| deutivacaftor 125 MG / tezacaftor 50 MG / vanzacaftor 10 MG Oral Tablet [Alyftrek] deutivacaftor | 1,206 | 23.8%
| T4 | 99.4% | - |
| deutivacaftor 50 MG / tezacaftor 20 MG / vanzacaftor 4 MG Oral Tablet [Alyftrek] deutivacaftor | 1,206 | 23.8%
| T4 | 99.4% | - |
| codeine sulfate 60 MG Oral Tablet codeine sulfate | 1,205 | 23.8%
| T3 | 0% | 3,569 |
| codeine sulfate 30 MG Oral Tablet codeine sulfate | 1,201 | 23.7%
| T3 | 0% | 3,569 |
| desonide 0.5 MG/ML Topical Lotion desonide | 1,199 | 23.7%
| T3 | 0% | 101,247 |
| glyburide 1.25 MG Oral Tablet glyburide | 1,199 | 23.7%
| T3 | 19.2% | 59,131 |
| glyburide 2.5 MG Oral Tablet glyburide | 1,199 | 23.7%
| T3 | 19.2% | 59,131 |
| glyburide 5 MG Oral Tablet glyburide | 1,199 | 23.7%
| T3 | 19.2% | 59,131 |
| {56 (tolvaptan 15 MG Oral Tablet [Jynarque]) } Pack [Jynarque 15/15 Carton] tolvaptan | 1,197 | 23.6%
| T5 | 91.7% | 486 |
| {28 (tolvaptan 15 MG Oral Tablet [Jynarque]) / 28 (tolvaptan 30 MG Oral Tablet [Jynarque]) } Pack [Jynarque 30/15 Carton] tolvaptan | 1,197 | 23.6%
| T5 | 91.7% | 486 |
| {28 (tolvaptan 15 MG Oral Tablet [Jynarque]) / 28 (tolvaptan 45 MG Oral Tablet [Jynarque]) } Pack [Jynarque 45/15 Carton] tolvaptan | 1,197 | 23.6%
| T5 | 91.7% | 486 |
| {28 (tolvaptan 30 MG Oral Tablet [Jynarque]) / 28 (tolvaptan 60 MG Oral Tablet [Jynarque]) } Pack [Jynarque 60/30 Carton] tolvaptan | 1,197 | 23.6%
| T5 | 91.7% | 486 |
| {28 (tolvaptan 30 MG Oral Tablet [Jynarque]) / 28 (tolvaptan 90 MG Oral Tablet [Jynarque]) } Pack [Jynarque 90/30 Carton] tolvaptan | 1,197 | 23.6%
| T5 | 91.7% | 486 |
| 24 HR nisoldipine 20 MG Extended Release Oral Tablet nisoldipine | 1,187 | 23.4%
| T3 | 0% | - |
| 24 HR nisoldipine 30 MG Extended Release Oral Tablet nisoldipine | 1,187 | 23.4%
| T3 | 0% | - |
| 24 HR nisoldipine 40 MG Extended Release Oral Tablet nisoldipine | 1,187 | 23.4%
| T3 | 0% | - |
| metronidazole 375 MG Oral Capsule metronidazole | 1,184 | 23.4%
| T2 | 0% | 1,528,785 |
| fluocinonide 1 MG/ML Topical Cream fluocinonide | 1,178 | 23.2%
| T2 | 0% | 379,768 |
| 0.4 ML methylnaltrexone bromide 20 MG/ML Prefilled Syringe [Relistor] methylnaltrexone bromide | 1,177 | 23.2%
| T4 | 66.9% | - |
| emtricitabine 200 MG / rilpivirine 25 MG / tenofovir disoproxil fumarate 300 MG Oral Tablet [Complera] emtricitabine | 1,174 | 23.2%
| T5 | 0% | 997 |
| 200 ML immunoglobulin G, human 50 MG/ML Injection [Gammaplex] immunoglobulin G, human | 1,173 | 23.1%
| T4 | 98.1% | 40 |
| BX Rating 24 HR methylphenidate hydrochloride 18 MG Extended Release Oral Tablet BX Rating | 1,167 | 23%
| T3 | 3.6% | - |
| fluorouracil 5 MG/ML Topical Cream fluorouracil | 1,166 | 23%
| T4 | 9.8% | 500,442 |
| codeine sulfate 15 MG Oral Tablet codeine sulfate | 1,162 | 22.9%
| T3 | 0% | 3,569 |
| hydrocodone bitartrate 5 MG / ibuprofen 200 MG Oral Tablet hydrocodone bitartrate | 1,151 | 22.7%
| T3 | 0% | 5,184 |
| vonoprazan 10 MG Oral Tablet [Voquezna] vonoprazan | 1,150 | 22.7%
| T3 | 93.4% | 48 |
| vonoprazan 20 MG Oral Tablet [Voquezna] vonoprazan | 1,150 | 22.7%
| T3 | 93.4% | 48 |
| tizanidine 2 MG Oral Capsule tizanidine | 1,144 | 22.6%
| T2 | 0% | 1,905,964 |
| tizanidine 4 MG Oral Capsule tizanidine | 1,144 | 22.6%
| T2 | 0% | 1,905,964 |
| tizanidine 6 MG Oral Capsule tizanidine | 1,141 | 22.5%
| T2 | 0% | 1,905,964 |
| nifurtimox 30 MG Oral Tablet [Lampit] nifurtimox | 1,135 | 22.4%
| T4 | 5.4% | - |
| nifurtimox 120 MG Oral Tablet [Lampit] nifurtimox | 1,135 | 22.4%
| T4 | 5.4% | - |
| pretomanid 200 MG Oral Tablet pretomanid | 1,134 | 22.4%
| T4 | 33.3% | 18 |
| hydrocodone bitartrate 10 MG / ibuprofen 200 MG Oral Tablet hydrocodone bitartrate | 1,130 | 22.3%
| T3 | 0% | 5,184 |
| phenytoin 25 MG/ML Oral Suspension [Dilantin] phenytoin | 1,129 | 22.3%
| T4 | 4.2% | 14,557 |
| chenodeoxycholate 250 MG Oral Tablet [Chenodal] chenodeoxycholate | 1,129 | 22.3%
| T5 | 91.7% | 38 |
| ospemifene 60 MG Oral Tablet [Osphena] ospemifene | 1,127 | 22.2%
| T3 | 77.6% | 4,511 |
| 84 HR estradiol 0.00208 MG/HR / norethindrone acetate 0.00583 MG/HR Transdermal System [Combipatch] estradiol | 1,122 | 22.1%
| T4 | 0% | 3,033 |
| 84 HR estradiol 0.00208 MG/HR / norethindrone acetate 0.0104 MG/HR Transdermal System [Combipatch] estradiol | 1,122 | 22.1%
| T4 | 0% | 3,033 |
| mesalamine 250 MG Extended Release Oral Capsule [Pentasa] mesalamine | 1,119 | 22.1%
| T3 | 0% | 95,185 |
| 60 ACTUAT testosterone 30 MG/ACTUAT Topical Solution | 1,112 | 21.9%
| T2 | 86.1% | - |
| 28 ACTUAT teriparatide 0.02 MG/ACTUAT Pen Injector [Forteo] | 1,109 | 21.9%
| T5 | 94.1% | 15,602 |
| dextroamphetamine sulfate 5 MG Oral Tablet [Zenzedi] dextroamphetamine sulfate | 1,106 | 21.8%
| T3 | 0% | 9,950 |
| dextroamphetamine sulfate 10 MG Oral Tablet [Zenzedi] dextroamphetamine sulfate | 1,106 | 21.8%
| T3 | 0% | 9,950 |
| buprenorphine 11.4 MG / naloxone 2.9 MG Sublingual Tablet [Zubsolv] buprenorphine | 1,103 | 21.8%
| T3 | 0% | 74,893 |
| buprenorphine 0.7 MG / naloxone 0.18 MG Sublingual Tablet [Zubsolv] buprenorphine | 1,103 | 21.8%
| T3 | 0% | 74,893 |
| buprenorphine 1.4 MG / naloxone 0.36 MG Sublingual Tablet [Zubsolv] buprenorphine | 1,103 | 21.8%
| T3 | 0% | 74,893 |
| buprenorphine 2.9 MG / naloxone 0.71 MG Sublingual Tablet [Zubsolv] buprenorphine | 1,103 | 21.8%
| T3 | 0% | 74,893 |
| buprenorphine 5.7 MG / naloxone 1.4 MG Sublingual Tablet [Zubsolv] buprenorphine | 1,103 | 21.8%
| T3 | 0% | 74,893 |
| buprenorphine 8.6 MG / naloxone 2.1 MG Sublingual Tablet [Zubsolv] buprenorphine | 1,103 | 21.8%
| T3 | 0% | 74,893 |
| 24 HR carvedilol phosphate 10 MG Extended Release Oral Capsule carvedilol phosphate | 1,099 | 21.7%
| T3 | 0% | - |
| 24 HR carvedilol phosphate 20 MG Extended Release Oral Capsule carvedilol phosphate | 1,099 | 21.7%
| T3 | 0% | - |
| 24 HR carvedilol phosphate 40 MG Extended Release Oral Capsule carvedilol phosphate | 1,099 | 21.7%
| T3 | 0% | - |
| 24 HR carvedilol phosphate 80 MG Extended Release Oral Capsule carvedilol phosphate | 1,099 | 21.7%
| T3 | 0% | - |
| ethacrynic acid 25 MG Oral Tablet ethacrynic acid | 1,093 | 21.6%
| T4 | 5.9% | 3,813 |
| cholic acid 50 MG Oral Capsule [Cholbam] cholic acid | 1,092 | 21.6%
| T5 | 100% | - |
| cholic acid 250 MG Oral Capsule [Cholbam] cholic acid | 1,092 | 21.6%
| T5 | 100% | - |
| 50 ML immunoglobulin G, human 100 MG/ML Injection [Gammaplex] immunoglobulin G, human | 1,085 | 21.4%
| T4 | 100% | 40 |
| temazepam 22.5 MG Oral Capsule temazepam | 1,084 | 21.4%
| T2 | 24.1% | 394,771 |
| magnesium chloride 0.00148 MEQ/ML / potassium chloride 0.00497 MEQ/ML / sodium acetate 0.027 MEQ/ML / sodium chloride 0.0899 MEQ/ML / sodium gluconate 5.02 MG/ML Injectable Solution [Plasmalyte A] magnesium chloride | 1,083 | 21.4%
| T3 | 8.6% | - |
| diroximel fumarate 231 MG Delayed Release Oral Capsule [Vumerity] diroximel fumarate | 1,081 | 21.3%
| T4 | 96.6% | 2,304 |
| amoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule [Talicia] amoxicillin | 1,080 | 21.3%
| T4 | 0% | 6,202,496 |
| 200 ML immunoglobulin G, human 100 MG/ML Injection [Gammaplex] immunoglobulin G, human | 1,068 | 21.1%
| T4 | 100% | 40 |
| glyburide 1.25 MG / metformin hydrochloride 250 MG Oral Tablet glyburide | 1,066 | 21%
| T3 | 19.6% | 59,131 |
| glyburide 2.5 MG / metformin hydrochloride 500 MG Oral Tablet glyburide | 1,066 | 21%
| T3 | 19.6% | 59,131 |
| glyburide 5 MG / metformin hydrochloride 500 MG Oral Tablet glyburide | 1,066 | 21%
| T3 | 19.6% | 59,131 |
| 100 ML immunoglobulin G, human 100 MG/ML Injection [Gammaplex] immunoglobulin G, human | 1,064 | 21%
| T4 | 100% | 40 |
| 1 ML abatacept 125 MG/ML Prefilled Syringe [Orencia] abatacept | 1,060 | 20.9%
| T4 | 98.8% | 1,749 |
| 1 ML abatacept 125 MG/ML Auto-Injector [Orencia] abatacept | 1,060 | 20.9%
| T4 | 98.8% | 1,749 |
| 0.4 ML abatacept 125 MG/ML Prefilled Syringe [Orencia] abatacept | 1,060 | 20.9%
| T4 | 98.8% | 1,749 |
| 0.7 ML abatacept 125 MG/ML Prefilled Syringe [Orencia] abatacept | 1,060 | 20.9%
| T4 | 98.8% | 1,749 |
| 30/70 Release 24 HR methylphenidate hydrochloride 10 MG Extended Release Oral Capsule | 1,060 | 20.9%
| T3 | 10.3% | - |
| 168 HR estradiol 0.00188 MG/HR / levonorgestrel 0.000625 MG/HR Transdermal System [Climara Pro] estradiol | 1,058 | 20.9%
| T4 | 8.1% | 1,983 |
| 0.2 ML adalimumab-ryvk 100 MG/ML Prefilled Syringe [Simlandi] adalimumab-ryvk | 1,052 | 20.8%
| T4 | 97.9% | - |
| 0.4 ML adalimumab-ryvk 100 MG/ML Auto-Injector [Simlandi] adalimumab-ryvk | 1,052 | 20.8%
| T4 | 97.9% | - |
| 0.4 ML adalimumab-ryvk 100 MG/ML Prefilled Syringe [Simlandi] adalimumab-ryvk | 1,052 | 20.8%
| T4 | 97.9% | - |
| 24 HR timolol 5 MG/ML Ophthalmic Solution timolol | 1,050 | 20.7%
| T3 | 0% | - |
| 30/70 Release 24 HR methylphenidate hydrochloride 20 MG Extended Release Oral Capsule | 1,050 | 20.7%
| T3 | 10.7% | - |
| 30/70 Release 24 HR methylphenidate hydrochloride 40 MG Extended Release Oral Capsule | 1,050 | 20.7%
| T3 | 10.7% | - |
| acetaminophen 300 MG / hydrocodone bitartrate 5 MG Oral Tablet acetaminophen | 1,048 | 20.7%
| T3 | 0% | 156 |
| 0.8 ML adalimumab-ryvk 100 MG/ML Auto-Injector [Simlandi] adalimumab-ryvk | 1,048 | 20.7%
| T4 | 97.9% | - |
| mavorixafor 100 MG Oral Capsule [Xolremdi] mavorixafor | 1,046 | 20.6%
| T4 | 100% | - |
| 30/70 Release 24 HR methylphenidate hydrochloride 60 MG Extended Release Oral Capsule | 1,046 | 20.6%
| T3 | 10.9% | - |
| 168 HR granisetron 0.129 MG/HR Transdermal System [Sancuso] granisetron | 1,045 | 20.6%
| T4 | 0% | 1,178 |
| calcitriol 0.000003 MG/MG Topical Ointment calcitriol | 1,044 | 20.6%
| T3 | 10% | 310,587 |
| promethazine hydrochloride 50 MG Rectal Suppository [Promethegan] promethazine hydrochloride | 1,041 | 20.5%
| T3 | 46.3% | 523,738 |
| pyridostigmine bromide 30 MG Oral Tablet pyridostigmine bromide | 1,041 | 20.5%
| T3 | 0% | 56,300 |
| dexamethasone 0.5 MG/ML / tobramycin 3 MG/ML Ophthalmic Suspension [Tobradex] dexamethasone | 1,033 | 20.4%
| T3 | 0% | 850,184 |